Vinay Chaudhry is a Neurologist in Baltimore, Maryland. Dr. Chaudhry is rated as a Distinguished provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Myasthenia Gravis, Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy Type 3, and Advanced Bronchoscopy.

Neil Porter is a Neurologist in Baltimore, Maryland. Dr. Porter is rated as a Distinguished provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Myasthenia Gravis, Mononeuritis Multiplex, Multiple Mononeuropathy, Riboflavin Transporter Deficiency Neuronopathy, and Gastrostomy.

Dr. Ricardo Roda earned a combined MD/PhD degree from University of Rochester and completed an adult neurology residency, followed by a clinical neuromuscular fellowship at Johns Hopkins University School of Medicine. During residency, Dr. Roda developed a special interest in both auto-immune disorders and genetic disorders. Following residency, he spent three years in neurogenetics branch of National Institute of Neurological Disorders and Stroke (NINDS) working with Dr. Craig Blackstone, focusing on the use of the newer DNA sequencing techniques in genetic diagnosis, and in establishing genotype/phenotype correlations neuromuscular disorders. His current clinical interests include developing testing strategies for undiagnosed genetic disorders and myasthenia gravis. Dr. Roda is rated as a Distinguished provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Spastic Paraplegia Type 7, Hereditary Spastic Paraparesis, Myasthenia Gravis, and Spastic Paraplegia Type 2.

Mohammad Khoshnoodi is a Neurologist in Baltimore, Maryland. Dr. Khoshnoodi is rated as an Advanced provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Peripheral Neuropathy, Guillain-Barre Syndrome, Chronic Polyradiculoneuritis, and Miller-Fisher Syndrome.

Dr. Brett Morrison specializes in neuromuscular disorders in adults including peripheral neuropathies, amyotrophic lateral sclerosis, myasthenia gravis and muscle diseases. Dr. Morrison is currently the site principal investigator for clinical trials investigating new treatments for chronic inflammatory demyelinating polyneuropathy (CIDP) and painful diabetic peripheral neuropathy. Dr. Morrison's research interests include investigations into the mechanisms of nerve regeneration and common peripheral neuropathies. Current research focuses on better understanding the role of the immune system in peripheral nerves and targeting these pathways for the development of new treatments. Dr. Brett Morrison received his M.D. and Ph.D. from Mount Sinai Medical School in New York City. He completed his medical internship at the University of Maryland and residency in neurology at The Johns Hopkins Hospital. He then completed a fellowship in Clinical Neurophysiology at The Johns Hopkins Hospital. Dr. Morrison is rated as an Advanced provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy Type 3, and Spinal Muscular Atrophy (SMA).

Charlene Hafer-Macko is a Neurologist in Baltimore, Maryland. Dr. Hafer-Macko is rated as a Distinguished provider by MediFind in the treatment of Myasthenia Gravis. Her top areas of expertise are Myasthenia Gravis, Multifocal Motor Neuropathy, Stroke, Chronic Inflammatory Demyelinating Polyneuropathy, and Gastrostomy.

Bonnie Gerecke is a Neurologist in Hagerstown, Maryland. Dr. Gerecke is rated as a Distinguished provider by MediFind in the treatment of Myasthenia Gravis. Her top areas of expertise are Myasthenia Gravis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, and Essential Tremor. Dr. Gerecke is currently accepting new patients.

Bruce Rabin is a Neurologist in Lutherville, Maryland. Dr. Rabin is rated as an Advanced provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Myasthenia Gravis, Cerebellar Degeneration, Relapsing Multiple Sclerosis (RMS), and Multiple Sclerosis (MS).

Peter Jin is a Neurologist in Baltimore, Maryland. Dr. Jin is rated as an Advanced provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy Type 3, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal Muscular Atrophy (SMA), and Gastrostomy.

Brian Salter is a Neurologist in Annapolis, Maryland. Dr. Salter is rated as an Advanced provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Chronic Inflammatory Demyelinating Polyneuropathy, Peripheral Neuropathy, Multiple Sclerosis (MS), and Relapsing Multiple Sclerosis (RMS).

James Bernheimer is a Neurologist in Baltimore, Maryland. Dr. Bernheimer is rated as an Advanced provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Opsoclonus-Myoclonus Syndrome, Peripheral Neuropathy, Benign Rolandic Epilepsy, and Myasthenia Gravis.

Lindsay Zilliox is a Neurologist in Baltimore, Maryland. Dr. Zilliox is rated as an Advanced provider by MediFind in the treatment of Myasthenia Gravis. Her top areas of expertise are Peripheral Neuropathy, Orthostatic Hypotension, Diabetic Neuropathy, Familial Dysautonomia, and Gastrostomy.

Andrew Mammen is a Neuromusculoskeletal Medicine specialist and a Neurologist in Baltimore, Maryland. Dr. Mammen is rated as an Experienced provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Myositis, Dermatomyositis, Polymyositis, and Necrotizing Myopathy (NM).

Nicholas Maragakis treats patients with motor neuron diseases, such as amyotrophic lateral sclerosis (ALS). This care is coordinated with the Johns Hopkins Center for ALS Specialty Care, a multidisciplinary clinic with expertise in treating patients with ALS and providing support to their caregivers. He serves as medical director of the ALS Clinical Trials Unit, an extension of the multidisciplinary clinic that seeks to facilitate opportunities for patients with ALS to participate in clinical trials that could advance the treatment of this disease. Dr. Maragakis is interested in the basic science of understanding neurodegenerative diseases, as well as the translational potential of therapeutic compounds developed in the laboratory. His fundamental research interest is in using stem cells — more specifically, stem cell-derived motor neurons and glia — for understanding the development and propagation of ALS. His laboratory has been involved in creating and characterizing lines of stem cells from patients with ALS using induced pluripotent stem cell (iPSC) methodologies. The laboratory has a large library of iPSCs from patients with familial ALS and from patients with sporadic ALS. The utilization of this library of iPSCs has facilitated the development of a spinal cord-specific iPSC-astrocyte/motor neuron co-culture system, which has been leveraged for the development of assays that can be used for both the basic understanding of ALS astrocyte and motor neuron biology as well as, eventually, drug screening for ALS therapeutics. His laboratory has taken its long-standing interests in astrocyte biology, as it relates to ALS, to develop a program that investigates astrocyte-specific mechanisms as contributors to the progression (both temporally and anatomically) of disease in ALS. In this vein, there is an interest in astrocytic glutamate transporters and, more recently, astrocyte hemichannels and gap junctions. Dr. Maragakis is rated as an Experienced provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, 15q11.2 Microdeletion, and Spinal Muscular Atrophy (SMA).

Prior to joining the Mid-Atlantic Epilepsy and Sleep Center, Dr. Jonathan Ross was Director of The New England Epilepsy Institute, a division of New England Neurological Associates (NENA) in Lawrence, Massachusetts. He also served as head of the Neurology division at NENA. After graduating medical school in 1991, Dr. Ross completed postgraduate training at Harvard Medical School and Boston University School of Medicine, and also served as Teaching Fellow at Harvard and Boston University. Dr. Ross is an active member of the American Epilepsy Society, American Clinical Neurophysiology Society, Massachusetts Medical Society, and the American Academy of Neurology. Dr. Ross is rated as an Experienced provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Seizures, Memory Loss, Autosomal Dominant Partial Epilepsy with Auditory Features, and Benign Rolandic Epilepsy.

Ruwani Gunawardane is a Neurologist in Fulton, Maryland. Dr. Gunawardane is rated as an Experienced provider by MediFind in the treatment of Myasthenia Gravis. Her top areas of expertise are Migraine, Transient Ischemic Attack (TIA), Cerebellar Degeneration, and Delirium.

Dr. Richard Leigh is an Assistant Professor of Neurology who is devoted to the diagnosis, treatment and prevention of cerebrovascular disease. He is an attending on the inpatient stroke service and an integral part of the Brain Attack Team. He also provides consultations and follow-up care for cerebrovascular disease in the outpatient setting. Dr. Richard Leigh was originally trained as a biomedical engineer at the Johns Hopkins University and subsequently went on to work at the National Institutes of Health where he developed brain imaging software. He then embarked on obtaining his medical degree from Case Western Reserve School of Medicine in his home town of Cleveland, Ohio. He completed his medical internship and neurology residency at New York Presbyterian Hospital Weill Cornell Medical Center where he received the Distinguished House Staff Award and was selected to be Chief Resident of Neurology. Returning to Johns Hopkins, he then completed a stroke fellowship and subsequently joined the faculty of the cerebrovascular division. Dr. Leigh currently sees patients at the Stroke Prevention Clinic, located in the Johns Hopkins Outpatient Center in Baltimore on Wednesday afternoons, and cares for patients in The Johns Hopkins Hospitals Brain Rescue Unit. Dr. Leigh is rated as an Experienced provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Stroke, Brown Syndrome, CACH Syndrome, Emphysema, and Thrombectomy.

Dr. Charlotte Sumner is a Professor of Neurology and Neuroscience at Johns Hopkins University School of Medicine. Dr. Sumner cares for patients with genetically-mediated neuromuscular diseases. Her practice is notable for a focus on individuals with inherited neuromuscular disorders of peripheral nerves and motor neurons, including spinal muscular atrophy (SMA) and Charcot-Marie-Tooth (CMT) disease. She co-directs the Johns Hopkins Muscular Dystrophy Association Care Center, the Spinal Muscular Atrophy (SMA), and the Charcot-Marie-Tooth (CMT) clinics, which deliver multidisciplinary clinical care, engage in international natural history studies, and provide cutting edge therapeutics. Dr. Sumner’s research focuses on developing treatments for degenerative disorders of motor neurons and peripheral nerves. Her laboratory uses human tissues and induced pluripotent cell lines, mouse models and cultured cells to characterize disease mechanisms and develop treatments. Dr. Charlotte Sumner received her medical degree from the University of Pennsylvania School of Medicine following undergraduate studies at Princeton University. She completed internal medicine internship and neurology residency at the University of California San Francisco, after which she returned to the east coast for a neuromuscular fellowship at Johns Hopkins and a neurogenetics fellowship in the Neurogenetics Branch at the National Institute of Neurological Disorders and Stroke. She joined the neurology faculty at Johns Hopkins in 2006. Dr. Sumner is rated as an Experienced provider by MediFind in the treatment of Myasthenia Gravis. Her top areas of expertise are Spinal Muscular Atrophy (SMA), Charcot-Marie-Tooth Disease, Primary Lateral Sclerosis, Spinal Muscular Atrophy Type 2, and Gastrostomy.

Dr. Probasco is a professor at the Johns Hopkins University School of Medicine Department of Neurology. He is the Vice Chair for Quality, Safety, and Service for the department. He also serves as the Director of the Johns Hopkins Division of Advanced Clinical Neurology as well as the Medical Director of the Johns Hopkins Inpatient General Neurology Service. He co-directs the Johns Hopkins Encephalitis Center and the Johns Hopkins Center for Refractory Status Epilepticus and Neuroinflammation. He cares for general neurology inpatients and outpatients, specializing in autoimmune and paraneoplastic syndromes as well as neurological immune-related adverse events following immunotherapies for cancer. After completing his undergraduate studies in biochemistry at the University of New Mexico, Dr. Probasco attended the University of Oxford as a Rhodes Scholar and earned a second undergraduate degree in psychology, philosophy and physiology. He went on to earn his medical degree at the University of California, San Francisco. He completed an internship in internal medicine at Johns Hopkins Bayview Medical Center and a residency in neurology at Johns Hopkins, where he was the faculty liaison/executive chief resident. He went on to complete an instructorship in inpatient general neurology at Johns Hopkins. Dr. Probasco’s research interests include increasing care value through improving outcomes, incorporation of patient experience of disease and treatment, the efficiency of care delivery, and diagnostic test utilization in general and specifically in relation to autoimmune and paraneoplastic neurological syndromes, including encephalitis. Finally, he is interested in the management of neurological immune-related adverse events following immunotherapies for the treatment of cancer. Dr. Probasco has been recognized at the departmental, institutional, and national levels for teaching and clinical excellence, including the American Academy of Neurology’s A.B. Baker Teacher Recognition Award and the Frank L. Coulson, Jr. Award from the Johns Hopkins Medicine Miller-Coulson Academy of Clinical Excellence. He is a past graduate of the Johns Hopkins Armstrong Institute Resident Scholars (AIRS) program in Patient Safety and Quality. As a faculty member, he was inducted into the Miller-Coulson Academy of Clinical Excellence in 2019. He serves as Editor-in-Chief of NEJM Journal Watch Neurology. Videos The impact of COVID-19 on the Department of Neurology‚Äôs clinical care and medical education programs. Dr. Probasco is rated as an Experienced provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Encephalitis, Anti-NMDA Receptor Encephalitis, Status Epilepticus, Creutzfeldt-Jakob Disease, and Gastrostomy.

Richard Babkes is a Neurologist in Ellicott City, Maryland. Dr. Babkes is rated as an Advanced provider by MediFind in the treatment of Myasthenia Gravis. His top areas of expertise are Essential Tremor, Peripheral Neuropathy, Neuralgia, and Dravet Syndrome.